查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1942457

2026年全球血糖值监测系统市场报告

Blood Glucose Monitoring Systems Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，血糖监测系统市场成长显着，预计将从2025年的176.6亿美元成长到2026年的190亿美元，复合年增长率为7.6%。过去几年的成长可归因于多种因素，例如全球糖尿病盛行率上升、人们对自我血糖监测的认识不断提高、侵入式血糖仪和试纸的早期商业化、居家医疗和门诊糖尿病护理的扩展，以及人们越来越重视血糖控制以减少併发症。

预计未来几年，血糖监测系统市场将维持强劲成长，2030年市场规模将达到246.8亿美元，复合年增长率（CAGR）为6.8%。预测期内的成长要素包括：对连续血糖监测和瞬时血糖监测系统的需求不断增长；可穿戴和植入式监测设备的普及率不断提高；远端和互联糖尿病管理解决方案的普及率不断提高；无创血糖感测技术的渗透率不断提高；以及日益广泛监测系统在2型糖尿病、1型糖尿病和妊娠期。预测期内的主要趋势包括：连续和即时血糖监测解决方案的普及率不断提高；加速向微创和无创血糖监测技术转型；携带式、家用和自我管理型血糖监测设备的使用日益普及；血糖监测在预防保健和慢性病管理中的应用不断扩大；以及更加註重提高糖尿病护理的准确性、便捷性和患者管理水平。

预计未来几年，糖尿病盛行率的不断上升将推动血糖监测系统市场的扩张。糖尿病病例的增加可归因于久坐的生活方式、不良的饮食习惯、人口老化和遗传易感性等因素。血糖监测系统对于追踪和管理血糖值、辅助疾病控制和预防併发症至关重要。例如，根据澳洲政府机构澳洲统计局2023年12月发布的数据，截至2022年，5.3%的澳洲人（约130万人）被诊断出患有糖尿病，男性（5.8%）和女性（4.9%）的盛行率相近。糖尿病盛行率持续上升，尤其是在老年人族群中，75岁以上族群的盛行率高达18.7%。 2型糖尿病最为常见，占所有病例的87.6%。出生于海外、居住在贫困地区以及残疾等因素与较高的糖尿病发生率有关。因此，糖尿病盛行率的不断上升预计将推动血糖监测系统市场的成长。

血糖监测系统市场的主要企业正致力于开发能够获取和管理即时数据的技术，例如混合闭合迴路系统和智慧型手机应用程式。混合闭合迴路系统可根据即时血糖值测量值自动注射胰岛素，进而改善糖尿病患者的血糖控制。例如，2024年2月，美国製造商德康（Dexcom）在多个欧洲国家推出了「Dexcom ONE+」。该系统整合了先进的传感器技术和便捷的用户友好功能，包括防水传感器、连续血糖监测发射器和智慧型手机应用程式。 Dexcom ONE+让使用者以及最多10个其他监测器即时监测血糖值，方便共用监测。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球血糖值监测系统市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 数位化、云端运算、巨量资料、网路安全
    • 人工智慧（AI）和自主人工智慧
    • 物联网、智慧基础设施和互联生态系统
    • 生物技术、基因组学和精准医学
    • 工业4.0和智慧製造
  • 主要趋势
    • 持续和即时血糖监测解决方案的应用日益广泛
    • 加速向微创和非侵入性血糖监测技术转型
    • 携带式、家用和自我监测血糖设备的使用日益普及
    • 在预防保健和慢性病管理中扩大血糖监测的应用
    • 重点在于提高糖尿病照护的准确性、便利性和患者管理水平

第五章 终端用户产业市场分析

  • 医院
  • 诊断检查室
  • 居家照护用户
  • 糖尿病护理诊所
  • 门诊治疗中心

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球血糖值监测系统市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球血糖值监测系统市场规模、比较及成长率分析
  • 全球血糖值监测系统市场表现：规模与成长，2020-2025年
  • 全球血糖值监测系统市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场总量（TAM）

第九章 市场细分

  • 按类型
  • 非侵入性、侵入性
  • 依设备类型
  • 连续血糖监测系统，自我监测系统
  • 按检查区域
  • 指尖采血、其他部位采血
  • 透过分销管道
  • 企业销售、零售
  • 透过使用
  • 2型糖尿病、第一型糖尿病、妊娠糖尿病
  • 按类型细分：非侵入性
  • 光学感测器、超音波感测器、电阻感测器、电磁感测器、泪液或唾液感测器
  • 按类型细分：侵袭性
  • 持续血糖监测（CGM）系统、自我血糖监测（SMBG）系统、植入式血糖监测设备、瞬时血糖监测系统

第十章 区域与国家分析

  • 全球血糖值监测系统市场：按地区、效能和预测划分，2020-2025年、2025-2030年预测、2035年预测
  • 全球血糖值监测系统市场：按国家、性能和预测划分，2020-2025 年、2025-2030 年预测、2035 年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 血糖值监测系统市场：竞争格局及市场占有率（2024年）
  • 血糖值监测系统市场：公司估值矩阵
  • 血糖值监测系统市场：公司简介
    • F. Hoffmann-La Roche Ltd.
    • Medtronic plc
    • Dexcom Inc.
    • SD Biosensor Co. Ltd.
    • Arkray Inc.

第37章：其他领先和创新企业

  • Abbott Laboratories, Ypsomed Holding AG, LifeScan IP Holdings LLC, Ascensia Diabetes Care Holdings AG, TaiDoc Technology Corporation, Nemaura Medical Inc., Bionime GmbH, Acon Laboratories Inc., Rossmax International Ltd, AgaMatrix Inc., A. Menarini Diagnostics Srl, Medisana GmbH, Intuity Medical Inc., GlucoTrack Ltd., Sinocare Inc.

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年血糖值监测系统市场：提供新机会的国家
  • 2030年血糖值监测系统市场：充满新机会的细分市场
  • 2030年血糖值监测系统市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME3MBGMS01_G26Q1

A blood glucose monitoring system is a medical device designed to measure and show the concentration of glucose in the blood. It typically includes a compact, portable meter and a test strip where a drop of blood from a fingertip is applied. This system plays a crucial role in diabetes management by enabling individuals to monitor and regulate their blood sugar levels.

There are two main types of blood glucose monitoring systems non-invasive and invasive. Non-invasive systems do not require drawing blood and include devices such as continuous glucose monitoring systems and self-monitoring blood glucose systems for fingertip and alternative site testing. These systems are sold through institutional and retail channels, serving applications in type 2 diabetes, type 1 diabetes, and gestational diabetes.

Tariffs are impacting the blood glucose monitoring systems market by increasing the cost of electronic sensors, semiconductor chips, batteries, plastics, and sterile consumables sourced through global supply chains, leading to higher device manufacturing and distribution costs. The impact is most visible in continuous glucose monitoring systems, self-monitoring blood glucose meters, and disposable test strip segments produced in Asia-Pacific and European manufacturing hubs dependent on imported raw materials and precision components. Retail and institutional buyers are experiencing price pressures and extended procurement cycles as tariff-related costs cascade through distributors and healthcare providers. Nonetheless, tariffs are also encouraging localized component sourcing, regional device assembly, and domestic innovation activities, which may strengthen supply resilience and support long-term market competitiveness.

The blood glucose monitoring systems market research report is one of a series of new reports from The Business Research Company that provides blood glucose monitoring systems market statistics, including blood glucose monitoring systems industry global market size, regional shares, competitors with a blood glucose monitoring systems market share, detailed blood glucose monitoring systems market segments, market trends and opportunities, and any further data you may need to thrive in the blood glucose monitoring systems industry. This blood glucose monitoring systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The blood glucose monitoring systems market size has grown strongly in recent years. It will grow from $17.66 billion in 2025 to $19 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to rise in global diabetes prevalence, increasing awareness of glucose self-monitoring, early commercialization of invasive glucose meters and test strips, expansion of home healthcare and outpatient diabetes care, growing emphasis on glycemic control to reduce complications.

The blood glucose monitoring systems market size is expected to see strong growth in the next few years. It will grow to $24.68 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to rising demand for continuous glucose monitoring and flash monitoring systems, increasing adoption of wearable and implantable monitoring devices, higher uptake of remote and connected diabetes management solutions, growing penetration of non-invasive glucose sensing technologies, expanding use of monitoring systems in type 2, type 1, and gestational diabetes care. Major trends in the forecast period include increasing adoption of continuous and real-time blood glucose monitoring solutions, rising shift toward minimally invasive and non-invasive glucose monitoring technologies, growing use of portable, home-based, and self-monitoring glucose devices, expansion of blood glucose monitoring in preventive and chronic disease management, focus on enhancing accuracy, convenience, and patient control in diabetes care.

The growing prevalence of diabetes is expected to drive the expansion of the blood glucose monitoring systems market in the coming years. The increase in diabetes cases can be attributed to factors such as sedentary lifestyles, poor dietary habits, aging populations, and genetic predisposition. Blood glucose monitoring systems are essential for tracking and managing blood sugar levels, supporting disease control, and preventing complications. For example, in December 2023, the Australian Bureau of Statistics, a government agency based in Australia, reported that in 2022, 5.3% of Australians, or around 1.3 million people, were diagnosed with diabetes, with similar rates between males (5.8%) and females (4.9%). The prevalence of diabetes has been steadily rising, particularly with age, reaching 18.7% among individuals aged 75 and older. Type 2 diabetes, which accounts for 87.6% of cases, is the most common form. Factors such as being born overseas, living in disadvantaged areas, and having a disability are linked to higher diabetes rates. As a result, the increasing prevalence of diabetes is expected to drive the growth of the blood glucose monitoring systems market.

Leading companies in the glucose monitoring systems market are focused on advancing technologies such as hybrid closed-loop systems and smartphone applications for real-time data access and management. Hybrid closed-loop systems automate insulin delivery based on real-time glucose readings, enhancing blood sugar control for individuals with diabetes. For instance, in February 2024, DexCom Inc., a US-based manufacturer, introduced Dexcom ONE+ in multiple European countries. This system integrates advanced sensor technology and user-friendly features, including a water-resistant sensor, a transmitter for continuous glucose monitoring, and a smartphone-compatible app. Dexcom ONE+ allows real-time monitoring of blood glucose levels by users and up to ten additional individuals, facilitating shared monitoring.

In September 2023, Abbott Laboratories expanded its diabetes management portfolio by acquiring Bigfoot Biomedical Inc., a US-based company specializing in diabetes management technology. This strategic move strengthens Abbott's capabilities in glucose monitoring and insulin management solutions for diabetic patients.

Major companies operating in the blood glucose monitoring systems market are F. Hoffmann-La Roche Ltd., Medtronic plc, Dexcom Inc., SD Biosensor Co. Ltd., Arkray Inc., Abbott Laboratories, Ypsomed Holding AG, LifeScan IP Holdings LLC, Ascensia Diabetes Care Holdings AG, TaiDoc Technology Corporation, Nemaura Medical Inc., Bionime GmbH, Acon Laboratories Inc., Rossmax International Ltd, AgaMatrix Inc., A. Menarini Diagnostics S.r.l., Medisana GmbH, Intuity Medical Inc., GlucoTrack Ltd., Sinocare Inc., Omron Healthcare Co Ltd, Trividia Health Inc.

North America was the largest region in the blood glucose monitoring systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the blood glucose monitoring systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the blood glucose monitoring systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The blood glucose monitoring systems market consists of sales of blood glucose meters, test strips, lancets, and lancing devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Blood Glucose Monitoring Systems Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses blood glucose monitoring systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for blood glucose monitoring systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The blood glucose monitoring systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Non-Invasive; Invasive
  • 2) By Device Type: Continuous Glucose Monitoring Systems; Self-Monitoring Blood Glucose Systems
  • 3) By Testing Site: Fingertip Testing; Alternate Site Testing
  • 4) By Distribution Channel: Institutional Sales; Retail Sales
  • 5) By Application: Type 2 Diabetes; Type 1 Diabetes; Gestational Diabetes
  • Subsegments:
  • 1) By Non-Invasive: Optical Sensors; Ultrasound-Based Sensors; Bioimpedance-Based Sensors; Electromagnetic Sensors; Tear Or Saliva-Based Sensors
  • 2) By Invasive: Continuous Glucose Monitoring (CGM) Systems; Self-Monitoring Blood Glucose (SMBG) Systems; Implantable Glucose Monitoring Devices; Flash Glucose Monitoring Systems
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Medtronic plc; Dexcom Inc.; SD Biosensor Co. Ltd.; Arkray Inc.; Abbott Laboratories; Ypsomed Holding AG; LifeScan IP Holdings LLC; Ascensia Diabetes Care Holdings AG; TaiDoc Technology Corporation; Nemaura Medical Inc.; Bionime GmbH; Acon Laboratories Inc.; Rossmax International Ltd; AgaMatrix Inc.; A. Menarini Diagnostics S.r.l.; Medisana GmbH; Intuity Medical Inc.; GlucoTrack Ltd.; Sinocare Inc.; Omron Healthcare Co Ltd; Trividia Health Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Blood Glucose Monitoring Systems Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Blood Glucose Monitoring Systems Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Blood Glucose Monitoring Systems Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Blood Glucose Monitoring Systems Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.4 Biotechnology, Genomics & Precision Medicine
    • 4.1.5 Industry 4.0 & Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Continuous And Real-Time Blood Glucose Monitoring Solutions
    • 4.2.2 Rising Shift Toward Minimally Invasive And Non-Invasive Glucose Monitoring Technologies
    • 4.2.3 Growing Use Of Portable, Home-Based, And Self-Monitoring Glucose Devices
    • 4.2.4 Expansion Of Blood Glucose Monitoring In Preventive And Chronic Disease Management
    • 4.2.5 Focus On Enhancing Accuracy, Convenience, And Patient Control In Diabetes Care

5. Blood Glucose Monitoring Systems Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Diagnostic Laboratories
  • 5.3 Homecare Users
  • 5.4 Diabetes Care Clinics
  • 5.5 Ambulatory Care Centers

6. Blood Glucose Monitoring Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Blood Glucose Monitoring Systems Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Blood Glucose Monitoring Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Blood Glucose Monitoring Systems Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Blood Glucose Monitoring Systems Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Blood Glucose Monitoring Systems Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Blood Glucose Monitoring Systems Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Blood Glucose Monitoring Systems Market Segmentation

  • 9.1. Global Blood Glucose Monitoring Systems Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Non-Invasive, Invasive
  • 9.2. Global Blood Glucose Monitoring Systems Market, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Continuous Glucose Monitoring Systems, Self-Monitoring Blood Glucose Systems
  • 9.3. Global Blood Glucose Monitoring Systems Market, Segmentation By Testing Site, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Fingertip Testing, Alternate Site Testing
  • 9.4. Global Blood Glucose Monitoring Systems Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Institutional Sales, Retail Sales
  • 9.5. Global Blood Glucose Monitoring Systems Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Type 2 Diabetes, Type 1 Diabetes, Gestational Diabetes
  • 9.6. Global Blood Glucose Monitoring Systems Market, Sub-Segmentation Of Non-Invasive, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Optical Sensors, Ultrasound-Based Sensors, Bioimpedance-Based Sensors, Electromagnetic Sensors, Tear Or Saliva-Based Sensors
  • 9.7. Global Blood Glucose Monitoring Systems Market, Sub-Segmentation Of Invasive, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Continuous Glucose Monitoring (CGM) Systems, Self-Monitoring Blood Glucose (SMBG) Systems, Implantable Glucose Monitoring Devices, Flash Glucose Monitoring Systems

10. Blood Glucose Monitoring Systems Market Regional And Country Analysis

  • 10.1. Global Blood Glucose Monitoring Systems Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Blood Glucose Monitoring Systems Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Blood Glucose Monitoring Systems Market

  • 11.1. Asia-Pacific Blood Glucose Monitoring Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Blood Glucose Monitoring Systems Market, Segmentation By Type, Segmentation By Device Type, Segmentation By Testing Site, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Blood Glucose Monitoring Systems Market

  • 12.1. China Blood Glucose Monitoring Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Blood Glucose Monitoring Systems Market, Segmentation By Type, Segmentation By Device Type, Segmentation By Testing Site, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Blood Glucose Monitoring Systems Market

  • 13.1. India Blood Glucose Monitoring Systems Market, Segmentation By Type, Segmentation By Device Type, Segmentation By Testing Site, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Blood Glucose Monitoring Systems Market

  • 14.1. Japan Blood Glucose Monitoring Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Blood Glucose Monitoring Systems Market, Segmentation By Type, Segmentation By Device Type, Segmentation By Testing Site, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Blood Glucose Monitoring Systems Market

  • 15.1. Australia Blood Glucose Monitoring Systems Market, Segmentation By Type, Segmentation By Device Type, Segmentation By Testing Site, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Blood Glucose Monitoring Systems Market

  • 16.1. Indonesia Blood Glucose Monitoring Systems Market, Segmentation By Type, Segmentation By Device Type, Segmentation By Testing Site, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Blood Glucose Monitoring Systems Market

  • 17.1. South Korea Blood Glucose Monitoring Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Blood Glucose Monitoring Systems Market, Segmentation By Type, Segmentation By Device Type, Segmentation By Testing Site, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Blood Glucose Monitoring Systems Market

  • 18.1. Taiwan Blood Glucose Monitoring Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Blood Glucose Monitoring Systems Market, Segmentation By Type, Segmentation By Device Type, Segmentation By Testing Site, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Blood Glucose Monitoring Systems Market

  • 19.1. South East Asia Blood Glucose Monitoring Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Blood Glucose Monitoring Systems Market, Segmentation By Type, Segmentation By Device Type, Segmentation By Testing Site, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Blood Glucose Monitoring Systems Market

  • 20.1. Western Europe Blood Glucose Monitoring Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Blood Glucose Monitoring Systems Market, Segmentation By Type, Segmentation By Device Type, Segmentation By Testing Site, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Blood Glucose Monitoring Systems Market

  • 21.1. UK Blood Glucose Monitoring Systems Market, Segmentation By Type, Segmentation By Device Type, Segmentation By Testing Site, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Blood Glucose Monitoring Systems Market

  • 22.1. Germany Blood Glucose Monitoring Systems Market, Segmentation By Type, Segmentation By Device Type, Segmentation By Testing Site, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Blood Glucose Monitoring Systems Market

  • 23.1. France Blood Glucose Monitoring Systems Market, Segmentation By Type, Segmentation By Device Type, Segmentation By Testing Site, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Blood Glucose Monitoring Systems Market

  • 24.1. Italy Blood Glucose Monitoring Systems Market, Segmentation By Type, Segmentation By Device Type, Segmentation By Testing Site, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Blood Glucose Monitoring Systems Market

  • 25.1. Spain Blood Glucose Monitoring Systems Market, Segmentation By Type, Segmentation By Device Type, Segmentation By Testing Site, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Blood Glucose Monitoring Systems Market

  • 26.1. Eastern Europe Blood Glucose Monitoring Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Blood Glucose Monitoring Systems Market, Segmentation By Type, Segmentation By Device Type, Segmentation By Testing Site, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Blood Glucose Monitoring Systems Market

  • 27.1. Russia Blood Glucose Monitoring Systems Market, Segmentation By Type, Segmentation By Device Type, Segmentation By Testing Site, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Blood Glucose Monitoring Systems Market

  • 28.1. North America Blood Glucose Monitoring Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Blood Glucose Monitoring Systems Market, Segmentation By Type, Segmentation By Device Type, Segmentation By Testing Site, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Blood Glucose Monitoring Systems Market

  • 29.1. USA Blood Glucose Monitoring Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Blood Glucose Monitoring Systems Market, Segmentation By Type, Segmentation By Device Type, Segmentation By Testing Site, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Blood Glucose Monitoring Systems Market

  • 30.1. Canada Blood Glucose Monitoring Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Blood Glucose Monitoring Systems Market, Segmentation By Type, Segmentation By Device Type, Segmentation By Testing Site, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Blood Glucose Monitoring Systems Market

  • 31.1. South America Blood Glucose Monitoring Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Blood Glucose Monitoring Systems Market, Segmentation By Type, Segmentation By Device Type, Segmentation By Testing Site, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Blood Glucose Monitoring Systems Market

  • 32.1. Brazil Blood Glucose Monitoring Systems Market, Segmentation By Type, Segmentation By Device Type, Segmentation By Testing Site, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Blood Glucose Monitoring Systems Market

  • 33.1. Middle East Blood Glucose Monitoring Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Blood Glucose Monitoring Systems Market, Segmentation By Type, Segmentation By Device Type, Segmentation By Testing Site, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Blood Glucose Monitoring Systems Market

  • 34.1. Africa Blood Glucose Monitoring Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Blood Glucose Monitoring Systems Market, Segmentation By Type, Segmentation By Device Type, Segmentation By Testing Site, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Blood Glucose Monitoring Systems Market Regulatory and Investment Landscape

36. Blood Glucose Monitoring Systems Market Competitive Landscape And Company Profiles

  • 36.1. Blood Glucose Monitoring Systems Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Blood Glucose Monitoring Systems Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Blood Glucose Monitoring Systems Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Dexcom Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. SD Biosensor Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Arkray Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Blood Glucose Monitoring Systems Market Other Major And Innovative Companies

  • Abbott Laboratories, Ypsomed Holding AG, LifeScan IP Holdings LLC, Ascensia Diabetes Care Holdings AG, TaiDoc Technology Corporation, Nemaura Medical Inc., Bionime GmbH, Acon Laboratories Inc., Rossmax International Ltd, AgaMatrix Inc., A. Menarini Diagnostics S.r.l., Medisana GmbH, Intuity Medical Inc., GlucoTrack Ltd., Sinocare Inc.

38. Global Blood Glucose Monitoring Systems Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Blood Glucose Monitoring Systems Market

40. Blood Glucose Monitoring Systems Market High Potential Countries, Segments and Strategies

  • 40.1 Blood Glucose Monitoring Systems Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Blood Glucose Monitoring Systems Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Blood Glucose Monitoring Systems Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer